You are the new audit senior on the Bad Blood, Inc. engagement. Bad Blood has developed equipment that will monitor a patient's blood for markers of various serious medical conditions. The company manufactures and distributes these devices and is working on other applications of the device. You have done some preliminary research into the client and learn the following: E. Theranos, CEO and Chairman of the Board of Directors, is the majority shareholder. E. Theranos is the owner of two other companies that provide marketing and distribution channels for the product. The FDA is investigating allegations that the company's device is not effective. There has been a high turnover of key IT and accounting personnel during the last two years. The company recently updated its accounting system. The accounting personnel had limited training sessions for the system but other employees had no formal training. The employee responsible for reconciling the accounts was hospitalized for three months and, as a result, the journals and ledgers have not been reconciled. Using the Audit Risk Model as a framework, discuss how you will evaluate the risks related to the audit of the company and how you will use this information to plan the audit